Alterations of anti-inflammatory lipids in plasma from women with chronic widespread pain - a case control study

Abstract Background Chronic widespread pain conditions (CWP) such as the pain associated with fibromyalgia syndrome (FMS) are significant health problems with unclear aetiology. Although CWP and FMS can alter both central and peripheral pain mechanisms, there are no validated markers for such altera...

Full description

Bibliographic Details
Main Authors: Niclas Stensson, Bijar Ghafouri, Björn Gerdle, Nazdar Ghafouri
Format: Article
Language:English
Published: BMC 2017-06-01
Series:Lipids in Health and Disease
Subjects:
Online Access:http://link.springer.com/article/10.1186/s12944-017-0505-7
id doaj-3b52bd6bdab246f683a4a52e30d08f82
record_format Article
spelling doaj-3b52bd6bdab246f683a4a52e30d08f822020-11-24T21:35:02ZengBMCLipids in Health and Disease1476-511X2017-06-011611910.1186/s12944-017-0505-7Alterations of anti-inflammatory lipids in plasma from women with chronic widespread pain - a case control studyNiclas Stensson0Bijar Ghafouri1Björn Gerdle2Nazdar Ghafouri3Pain and Rehabilitation Centre, Department of Medical and Health Sciences, Linköping UniversityPain and Rehabilitation Centre, Department of Medical and Health Sciences, Linköping UniversityPain and Rehabilitation Centre, Department of Medical and Health Sciences, Linköping UniversityPain and Rehabilitation Centre, Department of Medical and Health Sciences, Linköping UniversityAbstract Background Chronic widespread pain conditions (CWP) such as the pain associated with fibromyalgia syndrome (FMS) are significant health problems with unclear aetiology. Although CWP and FMS can alter both central and peripheral pain mechanisms, there are no validated markers for such alterations. Pro- and anti-inflammatory components of the immune system such as cytokines and endogenous lipid mediators could serve as systemic markers of alterations in chronic pain. Lipid mediators associated with anti-inflammatory qualities – e.g., oleoylethanolamide (OEA), palmitoylethanolamide (PEA), and stearoylethanolamide (SEA) – belong to N-acylethanolamines (NAEs). Previous studies have concluded that these lipid mediators may modulate pain and inflammation via the activation of peroxisome proliferator activating receptors (PPARs) and the activation of PPARs may regulate gene transcriptional factors that control the expression of distinct cytokines. Methods This study investigates NAEs and cytokines in 17 women with CWP and 21 healthy controls. Plasma levels of the anti-inflammatory lipids OEA, PEA, and SEA, the pro-inflammatory cytokines TNF-α, IL-1β, IL-6, and IL-8, and the anti-inflammatory cytokine IL-10 were investigated. T-test of independent samples was used for group comparisons. Bivariate correlation analyses, and multivariate regression analysis were performed between lipids, cytokines, and pain intensity of the participants. Results Significantly higher levels of OEA and PEA in plasma were found in CWP. No alterations in the levels of cytokines existed and no correlations between levels of lipids and cytokines were found. Conclusions We conclude that altered levels of OEA and PEA might indicate the presence of systemic inflammation in CWP. In addition, we believe our findings contribute to the understanding of the biochemical mechanisms involved in chronic musculoskeletal pain.http://link.springer.com/article/10.1186/s12944-017-0505-7Chronic widespread painInflammationN-acylethanolaminesPalmitoylethanolamideOleoylethanolamideCytokines
collection DOAJ
language English
format Article
sources DOAJ
author Niclas Stensson
Bijar Ghafouri
Björn Gerdle
Nazdar Ghafouri
spellingShingle Niclas Stensson
Bijar Ghafouri
Björn Gerdle
Nazdar Ghafouri
Alterations of anti-inflammatory lipids in plasma from women with chronic widespread pain - a case control study
Lipids in Health and Disease
Chronic widespread pain
Inflammation
N-acylethanolamines
Palmitoylethanolamide
Oleoylethanolamide
Cytokines
author_facet Niclas Stensson
Bijar Ghafouri
Björn Gerdle
Nazdar Ghafouri
author_sort Niclas Stensson
title Alterations of anti-inflammatory lipids in plasma from women with chronic widespread pain - a case control study
title_short Alterations of anti-inflammatory lipids in plasma from women with chronic widespread pain - a case control study
title_full Alterations of anti-inflammatory lipids in plasma from women with chronic widespread pain - a case control study
title_fullStr Alterations of anti-inflammatory lipids in plasma from women with chronic widespread pain - a case control study
title_full_unstemmed Alterations of anti-inflammatory lipids in plasma from women with chronic widespread pain - a case control study
title_sort alterations of anti-inflammatory lipids in plasma from women with chronic widespread pain - a case control study
publisher BMC
series Lipids in Health and Disease
issn 1476-511X
publishDate 2017-06-01
description Abstract Background Chronic widespread pain conditions (CWP) such as the pain associated with fibromyalgia syndrome (FMS) are significant health problems with unclear aetiology. Although CWP and FMS can alter both central and peripheral pain mechanisms, there are no validated markers for such alterations. Pro- and anti-inflammatory components of the immune system such as cytokines and endogenous lipid mediators could serve as systemic markers of alterations in chronic pain. Lipid mediators associated with anti-inflammatory qualities – e.g., oleoylethanolamide (OEA), palmitoylethanolamide (PEA), and stearoylethanolamide (SEA) – belong to N-acylethanolamines (NAEs). Previous studies have concluded that these lipid mediators may modulate pain and inflammation via the activation of peroxisome proliferator activating receptors (PPARs) and the activation of PPARs may regulate gene transcriptional factors that control the expression of distinct cytokines. Methods This study investigates NAEs and cytokines in 17 women with CWP and 21 healthy controls. Plasma levels of the anti-inflammatory lipids OEA, PEA, and SEA, the pro-inflammatory cytokines TNF-α, IL-1β, IL-6, and IL-8, and the anti-inflammatory cytokine IL-10 were investigated. T-test of independent samples was used for group comparisons. Bivariate correlation analyses, and multivariate regression analysis were performed between lipids, cytokines, and pain intensity of the participants. Results Significantly higher levels of OEA and PEA in plasma were found in CWP. No alterations in the levels of cytokines existed and no correlations between levels of lipids and cytokines were found. Conclusions We conclude that altered levels of OEA and PEA might indicate the presence of systemic inflammation in CWP. In addition, we believe our findings contribute to the understanding of the biochemical mechanisms involved in chronic musculoskeletal pain.
topic Chronic widespread pain
Inflammation
N-acylethanolamines
Palmitoylethanolamide
Oleoylethanolamide
Cytokines
url http://link.springer.com/article/10.1186/s12944-017-0505-7
work_keys_str_mv AT niclasstensson alterationsofantiinflammatorylipidsinplasmafromwomenwithchronicwidespreadpainacasecontrolstudy
AT bijarghafouri alterationsofantiinflammatorylipidsinplasmafromwomenwithchronicwidespreadpainacasecontrolstudy
AT bjorngerdle alterationsofantiinflammatorylipidsinplasmafromwomenwithchronicwidespreadpainacasecontrolstudy
AT nazdarghafouri alterationsofantiinflammatorylipidsinplasmafromwomenwithchronicwidespreadpainacasecontrolstudy
_version_ 1725946915108945920